LAG3 and leukemia: Staining for exhaustion markers LAG3 and TIGIT demonstrated an increase in expression on CD3+ T-cells in vehicle treated mice with leukemia between days 7 and 11, which is diminished by treatment with IL-12 (Fig. 6), generally consistent with the gene expression analyses.